GZD824
Bcr-Abl inhibitor,novel orally bioavailable
Product Specifications
CAS Number
1421783-64-3
Product Name Alternative
3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide dimethanesulfonate
Field of Research
Tyrosine Kinase Bcr-Abl
Purity
0.9846
Form
A solid
Solubility
≥36.25 mg/mL in DMSO; ≥33.95 mg/mL in H2O with ultrasonic; ≥4.71 mg/mL in EtOH with ultrasonic
Smiles
CC1=CC=C(C(NC2=CC=C(CN3CCN(C)CC3)C(C(F)(F)F)=C2)=O)C=C1C#CC4=CN=C5C(C=NN5)=C4.CS(=O)(O)=O.CS(=O)(O)=O
Molecular Formula
C29H27F3N6O·2CH4O3S
Molecular Weight
724.77
Shipping Conditions
Blue ice
Storage Conditions
Store at -20°C.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
S1014-33C-ML750 100 µL
SM22 alpha (Transgelin, Smooth Muscle Protein 22-alpha, TAGLN, Protein WS3-10, 22kD Actin-binding Protein, WS3-10, SM22) (MaxLight 750) discontinued
Sign In for Pricing
View Details 